Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease (Q44303706)

1 December 2017

title

Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease (English)

1 reference

1 December 2017

0 references

1 reference

1 reference

Eric Granholm

1 reference

1 December 2017

Shaunna Morris

1 reference

1 December 2017

Douglas Galasko

1 reference

1 December 2017

Clifford Shults

1 reference

1 December 2017

Erin Rogers

1 reference

1 December 2017

Boris Vukov

1 reference

1 December 2017

publication date

1 February 2003

1 reference

International Journal of Psychophysiology

1 December 2017

published in

1 reference

1 December 2017

1 reference

1 December 2017

1 reference

1 December 2017

page(s)

95-115

1 reference

Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

The 'eye test' in recognition of late-onset Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Selective loss of central cholinergic neurons in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

The effect of light intensity and dose of dilute pilocarpine eyedrops on pupillary constriction in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Is videopupillography useful in the diagnosis of Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Response of the pupil to tropicamide is not a reliable test for Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Changes in pupil reaction to light in Alzheimer's disease patients: a preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

The pupillary response to tropicamide in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Tacrine in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Pupil Dilation to Tropicamide Is Not Specific for Alzheimer Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Psychophysiological diagnostics in alcohol dependency: Fourier analysis of pupillary oscillations and the receptor test for determination of cholinergic deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Autonomic nervous function in Huntington's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

The rostral mesencephalon in Parkinson's disease and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Detection of dilated subarachnoid space around the optic nerve in patients with papilloedema using T2 weighted fast spin echo imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Influence of pupil size, anisocoria, and ambient light on pilocarpine miosis. Implications for supersensitivity testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Enhanced miotic response to topical dilute pilocarpine in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Drop the Alzheimer's drop test

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Detecting Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Optic nerve head drusen and pseudotumor cerebri

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

[Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome]

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Pupil dilation response to tropicamide: a biological test for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Pupillary response to tropicamide in patients with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Detecting Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Evaluation and significance of the pupillary light reflex in trauma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Disordered pupil reactivity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

The eyes don't have it in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Autonomic function in parkinsonian patients relates to duration of disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Bilateral skin conductance and the pupillary light-dark reflex: manipulation by chlorpromazine, haloperidol, scopolamine, and placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Necropsy evidence of central cholinergic deficits in senile dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Detecting Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Altered pupillary size and darkness and light reflexes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Topographical distribution of neurochemical changes in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

A potential noninvasive neurobiological test for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Focal pathology in the Edinger-Westphal nucleus explains pupillary hypersensitivity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Miosis during L-Dopa Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

The pupillary response in cognitive psychophysiology and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Detecting Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Pupillary response to topical tropicamide as a marker for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Pupillary light reflex latency in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Pupillary effects of levodopa therapy. Development of anisocoria in latent Horner's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

Modulation of auditory and visual cortex by selective attention is modality-dependent.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8760%2802%2900122-8

7 January 2021

10.1016/S0167-8760(02)00122-8

Identifiers

DOI

1 reference

1 December 2017

1 reference